Clinical Microbiology and Infection
Publisher: Elsevier · ISSN 1198-743X · 90 articles
- Predictors of severe measles outcomes in hospitalized patients in Jerusalem, 2025
- HHV-6 detection in children with encephalitis: a single-centre retrospective cohort study, 2010–2025
- ‘Hepatitis Delta in Spain: A Nationwide Prospective Characterization of Active Infection and Liver Disease Severity’ – Author’s reply
- How to navigate infectious disease mathematical models: a guide for clinicians
- Clinical spectrum and outcomes of pediatric Crimean–Congo hemorrhagic fever: a systematic review and individual patient data analysis
- Clinical heterogeneity and average treatment effects: consequences for superiority and non-inferiority trials
- ‘Sex differences in surgical left-sided infective endocarditis’ – Author’s reply
- Immunomodulatory therapies in bacterial community-acquired pneumonia: Current evidence and future directions
- Laboratory results as operationally constructed outputs
- Inflammatory endotypes in immunocompromised patients with community-acquired pneumonia: a framework for treatable traits
- Which trial do we need? evaluating plasma microbial cell–free DNA in blood culture–negative infective endocarditis
- From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin
- Surviving malignancy, navigating infection—a chimeric antigen receptor–T journey
- Extracting added value from existing tests—use of quantitative results from tuberculosis infection tests to improve the ability to predict progression to TB disease
- Malaria, the never-ending fight
- The promise of monoclonal antibody interventions in malaria: a narrative review
- Update on malaria vaccine deployment and challenges in the field
- Vector control for malaria: current tools and emerging challenges
- How to evaluate the robustness of causal findings in observational studies: application of E-values and bounding factors
- How do I screen for tuberculosis and provide tuberculosis preventive treatment in people with HIV?
- Mortality in infections caused by metallo-β-lactamase- versus serine carbapenemase-producing Enterobacterales: a systematic review and meta-analysis
- Infant infections associated with expressed breast milk: a scoping review
- Towards a reference methodology for bacteriophage susceptibility testing – position paper of the EUCAST Phage Susceptibility Testing Subcommittee
- A silent spirochete: Treponema pallidum in seronegative syphilis
- Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years
- Defining the unbound target exposure of teicoplanin, Part 1: Insights from the hollow-fibre system
- Defining the unbound target exposure of teicoplanin, Part 2: Dose individualization through population pharmacokinetic modelling
- Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort
- Cessation of amoxicillin-clavulanate selective reporting and association with antibiotic prescribing and Clostridioides difficile infection in Ontario, Canada, 2017-2024: an ecological study
- Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study